Drawing for ACENTRUS SPECIALTY

USPTO serial 87686450

ACENTRUS SPECIALTY

Reviewed by CopyMark Law Group

Reg. 6211485Status 700Renewal
Filing date
Status date
Registration date
Dec 1, 2020
Examiner
LEASER, ANDREW C
Law office
PUBLICATION AND ISSUE SECTION

What this means

This registration is in, or will soon enter, a USPTO maintenance window. Missing a Section 8 or Section 9 filing can cancel the registration.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with ACENTRUS SPECIALTY?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Get help with this Renewal, set up monitoring, or talk with CopyMark.
Get Attorney Assistance for just $748*

Plus Government fees of $650

Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Todd C. Basile

Todd C. Basile GREENBERG TRAURIG LLP2200 Ross Avenue, Suite 5200Dallas, TX 75201UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
035Business administration, information and management services of pharmacy and specialty pharmacy drug programs for health care systems, drug manufacturers, pharmacy benefit managers, medical and pharmaceutical consultants, and insurance and drug distribution companies; business administration and management of pharmacy and specialty pharmacy reimbursement programs and services; pharmaceutical procurement services, pharmaceutical cost management services and drug utilization review services; providing business, pricing, reimbursement benchmarking and other market intelligence information in the field of drug reimbursement for health care systems, prescribers and the pharmaceutical industry; promoting collaboration within the medical, scientific and research communities to achieve advances in the fields of healthcare and pharmaceuticals; business management of comprehensive programs involving specialty drug and pharmacy solutions; providing purchase pricing information of pharmacy and specialty pharmaceuticals for health care systemsACTIVEDec 4, 2017
036Financial administration, information, management, tracking and reporting services of pharmacy and specialty pharmacy drug programs for health care systems; financial administration and management of pharmacy reimbursement programs and services; and financial clearinghouse and research services, namely, providing financial research of pharmacy and specialty pharmaceuticals for health care systemsACTIVEDec 4, 2017

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Dec 1, 2025REM1COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED—
Aug 22, 2024ASCKASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY—
Dec 1, 2020R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Oct 28, 2020SUNANOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED—
Oct 27, 2020CNPRALLOWED PRINCIPAL REGISTER - SOU ACCEPTED—
Oct 8, 2020EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Oct 7, 2020SUPCSTATEMENT OF USE PROCESSING COMPLETE—
Oct 7, 2020EX3GSOU EXTENSION 3 GRANTED—
Sep 30, 2020IUAFUSE AMENDMENT FILED—
Sep 30, 2020EXT3SOU EXTENSION 3 FILED—
Sep 30, 2020EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Sep 30, 2020EISUTEAS STATEMENT OF USE RECEIVEDThe applicant filed a Statement of Use with specimens showing the mark in actual commerce. The USPTO will review the filing for compliance. If accepted, the mark can proceed to registration; if deficient, the USPTO may issue a requirement or office action.
Apr 8, 2020EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Apr 7, 2020EX2GSOU EXTENSION 2 GRANTED—
Apr 7, 2020CHANAPPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED—
Apr 6, 2020AITUCASE ASSIGNED TO INTENT TO USE PARALEGAL—
Apr 2, 2020EXT2SOU EXTENSION 2 FILED—
Apr 2, 2020EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Apr 1, 2020CHANAPPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED—
Apr 1, 2020TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Apr 1, 2020EWAFTEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS—
Apr 1, 2020ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Apr 1, 2020REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Apr 1, 2020COARTEAS CHANGE OF OWNER ADDRESS RECEIVED—
Oct 4, 2019EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Oct 2, 2019EX1GSOU EXTENSION 1 GRANTED—
Oct 2, 2019EXT1SOU EXTENSION 1 FILED—
Oct 2, 2019EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Apr 2, 2019NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Feb 19, 2019TMBNTTAB RELEASE CASE TO TRADEMARKS—
Feb 19, 2019OP.TOPPOSITION TERMINATED NO. 999999—
Feb 19, 2019OP.DOPPOSITION DISMISSED NO. 999999—
Oct 15, 2018OP.IOPPOSITION INSTITUTED NO. 999999—
May 17, 2018ETOFEXTENSION OF TIME TO OPPOSE RECEIVED—
Apr 17, 2018NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Apr 17, 2018PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Mar 28, 2018NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Mar 15, 2018ALIEASSIGNED TO LIE—
Mar 6, 2018CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Mar 6, 2018XAECEXAMINER'S AMENDMENT ENTERED—
Mar 6, 2018GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Mar 6, 2018GNEAEXAMINERS AMENDMENT E-MAILED—
Mar 6, 2018CNEAEXAMINERS AMENDMENT -WRITTEN—
Feb 27, 2018DOCKASSIGNED TO EXAMINER—
Nov 29, 2017NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Nov 18, 2017NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance